JCB logo
Carestream Gel Logic 212PRO
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 7 September 2004. doi:10.1083/jcb.200404024
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 166, Number 6, 901-912
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 8071K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, D. M.
Right arrow Articles by Turner, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, D. M.
Right arrow Articles by Turner, C. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

Phosphorylation of actopaxin regulates cell spreading and migration



Dominic M. Clarke, Michael C. Brown, David P. LaLonde, and Christopher E. Turner

Department of Cell Biology and Developmental Biology, State University of New York Upstate Medical University, Syracuse, NY 13210

Address correspondence to Christopher E. Turner, Dept. of Cell and Developmental Biology, State University of New York Upstate Medical University, 750 East Adams St., Syracuse, NY 13210. Tel.: (315) 464-8598. Fax: (315) 464-8535. email: turnerce{at}upstate.edu

Actopaxin is an actin and paxillin binding protein that localizes to focal adhesions. It regulates cell spreading and is phosphorylated during mitosis. Herein, we identify a role for actopaxin phosphorylation in cell spreading and migration. Stable clones of U2OS cells expressing actopaxin wild-type (WT), nonphosphorylatable, and phosphomimetic mutants were developed to evaluate actopaxin function. All proteins targeted to focal adhesions, however the nonphosphorylatable mutant inhibited spreading whereas the phosphomimetic mutant cells spread more efficiently than WT cells. Endogenous and WT actopaxin, but not the nonphosphorylatable mutant, were phosphorylated in vivo during cell adhesion/spreading. Expression of the nonphosphorylatable actopaxin mutant significantly reduced cell migration, whereas expression of the phosphomimetic increased cell migration in scrape wound and Boyden chamber migration assays. In vitro kinase assays demonstrate that extracellular signal-regulated protein kinase phosphorylates actopaxin, and treatment of U2OS cells with the MEK1 inhibitor UO126 inhibited adhesion-induced phosphorylation of actopaxin and also inhibited cell migration.

Key Words: phosphorylation; migration; adhesion; focal adhesions; Erk


Abbreviations used in this paper: CH, calponin homology; DN MEK1; dominant-negative MEK1; Erk, extracellular signal-regulated protein kinase; IGF, insulin-like growth factor; ILK, integrin-linked kinase; MLCK, myosin light chain kinase; PAK, p21-activated kinase; PBS, paxillin binding subdomain; Quint, quintuple; WT, wild-type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents